Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications

Proteomics - Clinical Applications

Volumn 3, Issue 6, 2009, Pages 636-653

  Bottoni, Patrizia ^a   Giardina, Bruno ^a   Scatena, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Biomarkers; Cellular stress response; Diagnostics; Neurodegeneration; Oncoproteomics

Indexed keywords

AUTOANTIBODY; GELDANAMYCIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 AUTOANTIBODY; HEAT SHOCK PROTEIN 90; IMATINIB; UNCLASSIFIED DRUG;

AORTA ANEURYSM; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CANCER INVASION; CANCER RESISTANCE; CARDIOVASCULAR DISEASE; CELLULAR STRESS RESPONSE; CHRONIC MYELOID LEUKEMIA; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; DRUG PROTEIN BINDING; FUNCTIONAL PROTEOMICS; GENE OVEREXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; STOMACH DISEASE;

EID: 70449589907     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800195     Document Type: Review

References (182)

1. Ritossa, F., A new puffing pattern induced by temperature shock and DNP in drosophila. Cell Mol. Life Sci. 1962, 18, 571-573.
2. Smith, D. F., Whitesell, L., Katsanis, E., Molecular chaperones: biology and prospects for pharmacological intervention. Pharmacol. Res. 1998, 50, 493-513.
3. Pockley, A. G., Heat shock proteins in health and disease: therapeutic targets or therapeutics agents? Expert Rev. Mol. Med. 2001, 3, 1-21.
4. Kim, H. J., Hwang, N. R., Lee, K. J., Heat shock responses for understanding diseases of protein denaturation. Mol. Cells 2007, 23, 123-131.
5. Soti, C., Nagy, E., Giricz, Z., Vigh, L. et al., Heat shock proteins as emerging therapeutic targets. Br. J. Pharmacol. 2005, 146, 769-780.
6. Westerheide, S. D., Morimoto, R. I., Heat shock response modulators as therapeutic tools for diseases of protein conformation. J. Biol. Chem. 2005, 280, 33097-33100.
7. Guy, G. R., Philip, R., Tan, Y. H., Analysis of cellular phosphoproteins by two-dimensional gel electrophoresis: applications for cell signaling in normal and cancer cells. Electrophoresis 1994, 15, 417-440.
8. Yu, S., Wong, Y. C., Wang, X. H., Ling, M. T. et al., Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer. Oncogene 2008, 27, 3313-3328.
9. Felts, S. J., Karnitz, L. M., Toft, D. O., Functioning of the Hsp90 machine in chaperoning checkpoint kinase I (Chk1) and the progesterone receptor (PR). Cell Stress Chaperones 2007, 12, 353-363.
10. Kim, H. L., Cassone, M., Otvos, L., Jr., Vogiatzi, P., HIF-1alpha and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations. Cancer Biol. Ther. 2008, 7, 10-14.
11. Whitesell, L., Lindquist, S. L., HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 2005, 5, 761-772.
12. Wang, X. Y., Chen, X., Oh, H. J., Repasky, E. et al., Characterization of native interaction of hsp110 with hsp25 and hsc70. FEBS Lett. 2000, 465, 98-102.
13. Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G. et al., Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 1990, 348, 166-168.
14. Freeman, B. C., Yamamoto, K. R., Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 2002, 296, 2232-2235.
15. Zeng, Y., Feng, H., Graner, M. W., Katsanis, E., Tumor derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood 2003, 101, 4485-4491.
16. Parmiani, G., Testori, A., Maio, M., Castelli, C. et al., Heat shock proteins and their use as anticancer vaccines. Clin. Cancer Res. 2004, 10, 8142-8146.
17. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., Garrido, C., Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 2007, 81, 15-27.
18. Calderwood, S. K., Mambula, S. S., Gray, P. J., Jr., Extracellular heat shock proteins in cell signaling and immunity. Ann. NY Acad. Sci. 2007, 1113, 28-39.
19. Li, W., Li, Y., Guan, S., Fan, J. et al., Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J. 2007, 26, 1221-1233.
20. Calderwood, S. K., Mambula, S. S., Gray, P. J., Jr., Theriault, J. R., Extracellular heat shock proteins in cell signaling. FEBS Lett. 2007, 581, 3689-3694.
21. Melendez, K., Wallen, E. S., Edwards, B. S., Mobarak, C. D. et al., Heat shock protein 70 and glycoprotein 96 are differentially expressed on the surface of malignant and nonmalignant breast cells. Cell Stress Chaperones 2006, 11, 334-342.
22. Multhoff, G., Heat shock proteins in immunity. Handb. Exp. Pharmacol. 2006, 172, 279-304.
23. Chen, Y., Voegeli, T. S., Liu, P. P., Noble, E. G., Currie, R. W., Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm. Allergy Drug Targets 2007, 6, 91-100.
24. Palotai, R., Szalay, M. S., Csermely, P., Chaperones as integrators of cellular networks: changes of cellular integrity in stress and diseases. IUBMB Life 2008, 60, 10-18.
25. Ghayour-Mobarhan, M., Lamb, D. J., Lovell, D. P., Livingstone, C. et al., Plasma antibody titres to heat shock proteins-60, -65 and-70: their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals. Scand. J. Clin. Lab. Invest. 2005, 65, 601-614.
26. van Noort, J. M., Stress proteins in CNS inflammation. J. Pathol. 2008, 214, 267-275.
27. Flohé, S. B., Bangen, J. M., Flohé, S., Agrawal, H. et al., Origin of immunomodulation after soft tissue trauma: potential involvement of extracellular heat-shock proteins. Shock 2007, 27, 494-502.
28. Detanico, T., Rodrigues, L., Sabritto, A. C., Keisermann, M. et al., Mycobacterial heat shock protein 70 induces interleukin-10 production: immunomodulation of synovial cell cytokine profile and dendritic cell maturation. Clin. Exp. Immunol. 2004, 135, 336-342.
29. Powers, M. V., Workman, P., Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett. 2007, 581, 3758-3769.
30. Zaarur, N., Gabai, V. L., Porco, J. A., Jr., Calderwood, S., Sherman, M. Y., Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Res. 2006, 66, 1783-1791.
31. Routsias, J. G., Tzioufas, A. G., The role of chaperone proteins in autoimmunity. Ann. NY Acad. Sci. 2006, 1088, 52-64.
32. Wieten, L., Broere, F., van der Zee, R., Koerkamp, E. K. et al., Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as antiinflammatory immuno-modulators? FEBS Lett. 2007, 581, 3716-3722.
33. Yujun, H., Yuzhang, W., Zhirong, M., Wanlin, L. et al., Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin. Appl. 2007, 1, 336-342.
34. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Déjàvu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
35. Bons, J. A. P., van Dieijen-Visser, M. P., Wodzig, W. K. W. H., Clinical proteomics in chronic inflammatory diseases: a review. Proteomics Clin. Appl. 2007, 1, 1123-1133.
36. Zhang, D., Tai, L. K., Wong, L. L., Putti, T. C. et al., Proteomic characterization of differentially expressed proteins in breast cancer: expression of hnRNP H1, RKIP and GRP78 is strongly associated with HER-2/ neu status. Proteomics Clin. Appl. 2008, 2, 99-107.
37. Rahmani, M., Reese, E., Dai, Y., Bauer, C. et al., Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl1cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change. Mol. Pharmacol. 2005, 67, 1166-1176.
38. Shimamura, T., Lowell, A. M., Engelman, J. A., Shapiro, G. I., Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Res. 2005, 65, 6401-6408.
39. Calderwood, S. K., Khaleque, M. A., Sawyer, D. B., Ciocca, D. R., Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem. Sci. 2006, 31, 164-172.
40. Sur, R., Lyte, P. A., Southall, M. D., Hsp27 regulates proinflammatory mediator release in keratinocytes by modulating NF-kappaB signaling. J. Invest. Dermatol. 2008, 128, 1116-1122.
41. Arthur, J. C., Lich, J. D., Aziz, R. K., Kotb, M., Ting, J. P., Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaB-inducing kinase. J. Immunol. 2007, 179, 6291-6296.
42. Zhou, J., Schmid, T., Frank, R., Brune, B., PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J. Biol. Chem. 2004, 279, 13506-13513.
43. Keezer, S. M., Ivie, S. E., Krutzsch, H. C., Tandle, A. et al., Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res. 2003, 63, 6405-6412.
44. Hoang, A. T., Huang, J., Rudra-Ganguly, N., Zheng, J. et al., A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma. Am. J. Pathol. 2000, 156, 857-864.
45. Routsias, J. G., Tzioufas, A. G., The role of chaperone proteins in autoimmunity. Ann. NY Acad. Sci. 2006, 1088, 52-64.
46. Wieten, L., Broere, F., van der Zee, R., Koerkamp, E. K. et al., Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as antiinflammatory immuno-modulators? FEBS Lett. 2007, 581, 3716-3722.
47. Pockley, A., Muthana, M., The Pro- and Anti-Inflammatory Properties of the Stress Protein GP96 in Heat Shock Proteins: Potent Mediators of Inflammation and Immunity, Asea, A. A. and De Maio, A. (Eds.), Springer, Dordrecht, The Netherlands 2007, pp. 309-320.
48. Pockley, A., Muthana, M., Calderwood, S. K., The dual immunoregulatory roles of stress proteins. TIBS 2008, 33, 71-79.
49. Sosa, M. S., Girotti, M. R., Salvatierra, E., Prada, F., Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. Proteomics 2007, 7, 4123-4134.
50. Sarto, C., Valsecchi, C., Magni, F., Tremolada, L. et al., Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 2004, 4, 2252-2260.
51. Feng, J. T., Liu, Y. K., Song, H. Y., Dai, Z. et al., Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005, 5, 4581-4588.
52. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) upregulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
53. Mori-Iwamoto, S., Kuramitsu, Y., Ryozawa, S., Mikuria, K. et al., Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int. J. Oncol. 2007, 31, 1345-1350.
54. Lee, S. C., Sim, N., Clement, M. V., Yadav, S. K., Pervaiz, S., Dominant negative Rac1 attenuates paclitaxel-induced apoptosis in human melanoma cells through upregulation of heat shock protein 27: a functional proteomic analysis. Proteomics 2007, 7, 4112-4122.
55. Wong, C. S., Wong, V. W., Chan, C. M., Ma, B. B. et al., Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol. Rep. 2008, 20, 89-98.
56. Tong, A., Zhang, H., Li, Z., Gou, L. et al., Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. Cancer Chemother. Pharmacol. 2008, 61, 791-802.
57. Ellen, A., Nollen, A., Morimoto, R. I., Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J. Cell Sci. 2002, 115, 2809-2816.
58. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T. et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
59. Bottoni, P., Giardina, B., Martorana, G. E., Zuppi, C. et al., A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. J. Cell. Mol. Med. 2005, 9, 462-467.
60. Jazii, F. R., Najafi, Z., Malekzadeh, R., Conrads, T. P. et al., Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J. Gastroenterol. 2006, 12, 7104-7112.
61. Dundas, S. R., Lawrie, L. C., Rooney, P. H., Murray, G. I., Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J. Pathol. 2005, 205, 74-81.
62. Hu, W., Wu, W., Verschraegen, C. F., Chen, L. et al., Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor. Proteomics 2003, 3, 1904-1911.
63. Short, D. M., Heron, I. D., Birse-Archbold, J. L., Kerr, L. E. et al., Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics. Proteomics 2007, 7, 3085-3096.
64. Voss, T., Ahorn, H., Haberl, P., Dohner, H. et al., Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int. J. Cancer 2001, 91, 180-186.
65. Zhang, R., Tremblay, T. L., McDermid, A., Thibault, P., Stanimirovic, D., Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia 2003, 42, 194-208.
66. Castagna, A., Antonioli, P., Astner, H., Hamdan, M. et al., A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 2004, 4, 3246-3267.
67. Allal, A. S., Kahne, T., Reverdin, A. K., Lippert, H. et al., Radioresistance-related proteins in rectal cancer. Proteomics 2004, 4, 2261-2269.
68. Smith, L., Welham, K. J., Watson, M. B., Drew, P. J. et al., The proteomic analysis of cisplatin resistance in breast cancer cells. Oncol. Res. 2007, 16, 497-506.
69. Pocaly, M., Lagarde, V., Etienne, G., Dupouy, M. et al., Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance. Proteomics 2008, 8, 2394-2406.
70. Fujita, Y., Nakanishi, T., Miyamoto, Y., Hiramatsu, M. et al., Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett. 2008, 263, 280-290.
71. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006, 6, 3894-3900.
72. Sreedhar, A. S., Kalmár, E., Csermely, P., Shen, Y. F., Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett. 2004, 562, 11-15.
73. Zurawska, A., Urbanski, J., Bieganowski, P., Hsp90n - an accidental product of a fortuitous chromosomal translocation rather than a regular Hsp90 family member of human proteome. Biochim. Biophys. Acta 2008, 1784, 1844-1846.
74. Rao, R., Fiskus, W., Yang, Y., Lee, P. et al., HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood 2008, 112, 1886-1893.
75. Yang, Y., Rao, R., Shen, J., Tang, Y. et al., Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res. 2008, 68, 4833-4842.
76. Hayashi, E., Kuramitsu, Y., Okada, F., Fujimoto, M. et al., Proteomic profiling for cancer progression: differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics 2005, 5, 1024-1032.
77. Butler, G. S., Dean, R. A., Tam, E. M., Overall, C. M., Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol. Cell. Biol. 2008, 28, 4896-4914.
78. Schumacher, J. A., Crockett, D. K., Elenitoba-Johnson, K. S., Lim, M. S., Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells. Proteomics 2007, 7, 2603-2616.
79. Maloney, A., Clarke, P. A., Naaby-Hansen, S., Stein, R. et al., Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 2007, 67, 3239-3253.
80. Rehman, A., Chahal, M. S., Tang, X., Bruce, J. E. et al., Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells. Breast Cancer Res. 2005, 7, R765-R774.
81. Ghobrial, I. M., McCormick, D. J., Kaufmann, S. H., Leontovich, A. A. et al., Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 2005, 105, 3722-3730.
82. Hatjiharissi, E., Ngo, H., Leontovich, A. A., Leleu, X. et al., Proteomic analysis of waldenstrom macroglobulinemia. Cancer Res. 2007, 67, 3777-3784.
83. Rees-Unwin, K. S., Craven, R. A., Davenport, E., Hanrahan, S. et al., Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma. Br. J. Haematol. 2007, 139, 559-567.
84. Saint-Guirons, J., Zeqiraj, E., Schumacher, U., Greenwell, P., Dwek, M., Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA). Proteomics 2007, 7, 4082-4089.
85. Sun, W., Xing, B., Sun, Y., Du, X. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 2007, 6, 1798-1808.
86. Falsone, S. F., Gesslbauer, B., Rek, A., Kungl, A. J., A proteomic approach towards the Hsp90-dependent ubiquitinylated proteome. Proteomics 2007, 7, 2375-2383.
87. Wilson, P. W., CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation 2004, 110, e568-e571.
88. Gerszten, R. E., Wang, T. J., The search for new cardiovascular biomarkers. Nature 2008, 451, 949-952.
89. Wick, G., Heat-shock proteins and atherosclerosis. Circulation 2006, 114, 870-872.
90. Xu, Q., Infections, heat shock proteins, and atherosclerosis. Curr. Opin. Cardiol. 2003, 18, 245-252.
91. Knoflach, M., Kiechl, S., Mayrl, B., Kind, M. et al., T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 2007, 195, 333-338.
92. Pockley, A. G., Wu, R., Lemne, C., Kiessling, R. et al., Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000, 36, 303-307.
93. Dybdahl, B., Slordahl, S. A., Waage, A., Kierulf, P. et al., Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005, 91, 299-304.
94. Knowlton, A. A., Kapadia, S., Torre-Amione, G., Durand, J. B. et al., Differential expression of heat shock proteins in normal and failing human hearts. J. Mol. Cell. Cardiol. 1998, 30, 811-818.
95. Kanwar, R. K., Kanwar, J. R., Wang, D., Ormrod, D. J., Krissansen, G. W., Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb. Vasc. Biol. 2001, 21, 1991-1997.
96. Mazzone, A., Epistolato, M. C., De Caterina, R., Storti, S. et al., Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J. Am. Coll. Cardiol. 2004, 43, 1670-1676.
97. Biasucci, L. M., Liuzzo, G., Ciervo, A., Petrucca, A. et al., Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003, 107, 3015-3017.
98. Depre, C., Kim, S. J., John, A. S., Huang, Y. et al., Program of cell survival underlying human and experimental hibernating myocardium. Circ. Res. 2004, 95, 433-440.
99. Feuerstein, G. Z., Young, P. R., Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. Cardiovasc. Res. 2000, 45, 560-569.
100. Zhao, Y., Wang, W., Qian, L., Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis. Cell Stress Chaperones 2007, 12, 83-95.
101. Giannessi, D., Colotti, C., Maltinti, M., Del Ry, S. et al., Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 2007, 12, 265-274.
102. Scheler, C., Muller, E. C., Stahl, J., Muller-Werdan, U. et al., Identification and characterization of heat shock protein 27 protein species in human myocardial two-dimensional electrophoresis patterns. Electrophoresis 1997, 18, 2823-2831.
103. Heinke, M. Y., Wheeler, C. H., Chang, D., Einstein, R. et al., Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 1998, 19, 2021-2030.
104. Weekes, J., Wheeler, C. H., Yan, J. X., Weil, J. et al., Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999, 20, 898-906.
105. Portig, I., Pankuweit, S., Lottspeich, F., Maisch, B., Identification of stress proteins in endothelial cells. Electrophoresis 1996, 17, 803-808.
106. Molero, L., García-Mendez, A., Alonso-Orgaz, S., Carrasco, C. et al., Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells. Clin. Sci. 2005, 109, 457-463.
107. Kanwar, R. K., Kanwar, J. R., Wang, D., Ormrod, D. J., Krissansen, G. W., Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler. Throm. Vasc. Biol. 1991, 21, 1991-1997.
108. Hirono, S., Dibrov, E., Hurtado, C., Kostenuk, A. et al., Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ. Res. 2003, 93, 710-716.
109. Quintana, F. J., Carmi, P., Mor, F., Cohen, I. R., Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum. 2004, 50, 3712-3720.
110. Pawlowska, Z., Baranska, P., Jerczynska, H., Koziolkiewicz, W., Cierniewski, C. S., Heat shock proteins and other components of cellular machinery for protein synthesis are up-regulated in vascular endothelial cell growth factor-activated human endothelial cells. Proteomics 2005, 5, 1217-1227.
111. Dupont, A., Corseaux, D., Dekeyzer, O., Drobecq, H. et al., The proteome and secretome of human arterial smooth muscle cells. Proteomics 2005, 5, 585-596.
112. Bason, C., Corrocher, R., Lunardi, C., Puccetti, P. et al., Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003, 362, 1971-1977.
113. Otto, A., Thiede, B., Müller, E. C., Scheler, C. et al., Identification of human myocardial proteins separated by two-dimensional electrophoresis using an effective sample preparation for mass spectrometry. Electrophoresis 1996, 17, 1643-1650.
114. Thiede, B., Otto, A., Zimny-Arndt, U., Müller, E. C., Jungblut, P., Identification of human myocardial proteins separated by two-dimensional electrophoresis with matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 1996, 17, 588-599.
115. Dunn, M. J., Corbett, J. M., Wheeler, C. H., HSC-2D PAGE and the two dimensional gel electrophoresis database of dog heart proteins. Electrophoresis 1997, 18, 2795-2802.
116. Evans, G., Wheeler, C. H., Corbett, J. M., Dunn, M. J., Construction of HSC-2D PAGE: a two-dimensional gel electrophoresis database of heart proteins. Electrophoresis 1997, 18, 471-479.
117. Jungblut, P., Otto, A., Zeindl-Eberhart, E., Plessner, K. P. et al., Protein composition of the human heart: the construction of a myocardial two-dimensional electrophoresis database. Electrophoresis 1994, 15, 685-707.
118. Wang, X. L., Fu, A., Spiro, C., Lee, H. C., Clinical application of proteomics approaches in vascular diseases. Proteomics Clin. Appl. 2008, 2, 238-250.
119. Scatena, R., Bottoni, P., Giardina, B., Modulation of cancer cell line differentiation. A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis and therapy of cancer. Proteomics Clin. Appl. 2008, 2, 229-237.
120. Berhane, B. T., Zong, C., Liem, D. A., Huang, A. et al., Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project Pilot Phase. Proteomics 2005, 5, 3520-3530.
121. Martin-Ventura, J. L., Duran, M. C., Blanco-Colio, L. M., Meilhac, O. et al., Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110, 2216-2219.
122. Park, H. K., Park, E. C., Bae, S. W., Park, M. Y. et al., Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114, 886-893.
123. De Souza, A. I., Wait, R., Mitchell, A. G., Banner, N. R. et al., Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ. Res. 2005, 97, 192-198.
124. Liao, D. F., Jin, Z. G., Baas, A. S., Daum, G. et al., Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 2000, 275, 189-196.
125. Martin-Ventura, J. L., Nicolas, V., Houard, X., Blanco-Colio, L. M. et al., Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1337-1343.
126. Huot, J., Houle, F., Spitz, D. R., Landry, J., HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res. 1996, 56, 273-279.
127. Kardys, I., Rifai, N., Meilhac, O., Michel, J. B. et al., Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin. Chem. 2008, 54, 139-146.
128. Arnott, D., O'Connell, K. L., King, K. L., Stults, J. T., An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal. Biochem. 1998, 258, 1-18.
129. Faber,M. J., Dalinghaus,M., Lankhuizen, I.M., Bezstarosti, K. et al., Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 2005, 5, 2519-2530.
130. McGregor, E., Kempster, L., Wait, R., Gosling, M. et al., F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol. Cell. Proteomics 2004, 3, 115-124.
131. Matt, P., Fu, Z., Carrel, T., Huso, D. L. et al., Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J. Mol. Cell. Cardiol. 2007, 43, 792-801.
132. Walker, V. E., Atanasiu, R., Lam, H., Shrier, A., Cochaperone FKBP38 promotes HERG trafficking. J. Biol. Chem. 2007, 282, 23509-23516.
133. Robinson, M. B., Tidwell, J. L., Gould, T., Taylor, A. R. et al., Extracellular heat shock protein 70: a critical component for motoneuron survival. J. Neurosci. 2005, 25, 9735-9745.
134. Clayton, A., Turkes, A., Navabi, H., Mason, M. D., Tabi, Z., Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 2005, 118, 3631-3638.
135. Davies, E. L., Bacelar, M. M., Marshall, M. J., Johnson, E. et al., Heat shock proteins form part of a danger signal cascade in response to lipopolysaccharide and GroEL. Clin. Exp. Immunol. 2006, 145, 183-189.
136. Hightower, L. E., Guidon, P. T., Jr., Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell. Physiol. 1989, 138, 257-266.
137. Moseley, P., Stress proteins and the immune response. Immunopharmacology 2000, 48, 299-302.
138. Oizumi, S., Strbo, N., Pahwa, S., Deyev, V., Podack, E. R., Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes. J. Immunol. 2007, 179, 2310-2317.
139. Ferrarini, M., Heltai, S., Zocchi, M. R., Rugarli, C., Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 1992, 51, 613-619.
140. Kaur, J., Das, S. N., Srivastava, A., Ralhan, R., Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features. Oral Oncol. 1998, 34, 93-98.
141. Multhoff, G., Heat shock protein 72 (HSP72), a hyperthermia inducible immunogenic determinant on leukemic K562 and Ewing's sarcoma cells. Int. J. Hyperthermia 1997, 13, 39-48.
142. Roigas, J., Wallen, E. S., Loening, S. A., Moseley, P. L., Heat shock protein (HSP72) surface expression enhances the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells. Adv. Exp. Med. Biol. 1998, 451, 225-229.
143. Strandell, E., Buschard, K., Saldeen, J., Welsh, N., Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat islet beta-cells, but not in alpha-cells. Immunol. Lett. 1995, 48, 145-148.
144. Boog, C. J., de Graeff-Meeder, E. R., Lucassen, M. A., van der Zee, R. et al., Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J. Exp. Med. 1992, 175, 1805-1810.
145. Elias, D., Reshef, T., Birk, O. S., van der Zee, R., Walker, M. D., Cohen, I. R., Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 1991, 88, 3088-3091.
146. Abulafia-Lapid, R., Elias, D., Raz, I., Keren-Zur, Y. et al., T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 1999, 12, 121-129.
147. Huurman, V. A., van der Meide, P. E., Duinkerken, G., Willemen, S. et al., Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin. Exp. Immunol. 2008, 152, 488-497.
148. Lu, H., Yang, Y., Allister, E. M., Wijesekara, N., Wheeler, M. B., The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol. Cell. Proteomics 2008, 7, 1434-1451.
149. Laybutt, D. R., Preston, A. M., Akerfeldt, M. C., Kench, J. G. et al., Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007, 50, 752-763.
150. Li, B. Y., Cheng, M., Gao, H. Q., Ma, Y. B. et al., Back-regulation of six oxidative stress proteins with grape seed proanthocyanidin extracts in rat diabetic nephropathy. J. Cell. Biochem. 2008, 104, 668-679.
151. Ahmed, M., Bergsten, P., Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry. Diabetologia 2005, 48, 477-485.
152. D'Hertog, W., Overbergh, L., Lage, K., Ferreira, G. B. et al., Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved. Mol. Cell. Proteomics 2007, 6, 2180-2199.
153. Larsen, C. M., Faulenbach, M., Vaag, A., Volund, A. et al., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356, 1517-1526.
154. Sundsten, T., Ortsater, H., Proteomics in diabetes research. Mol. Cell. Endocrinol. 2009, 297, 93-103.
155. Fukuda, Y., Yotsuyanagi, H., Ooka, S., Sekine, T. et al., Identification of a new autoantibody in patients with chronic hepatitis. Hum. Immunol. 2004, 65, 1530-1538.
156. Shingai, R., Maeda, T., Onishi, S., Yamamoto, Y., Auto-antibody against 70 kD heat shock protein in patients with autoimmune liver diseases. J. Hepatol. 1995, 23, 382-390.
157. Tahiri, F., Le Naour, F., Huguet, S., Lai-Kuen, R. et al., Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology 2008, 47, 937-948.
158. Tanaka, S., Kimura, Y., Mitani, A., Yamamoto, G. et al., Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 1999, 163, 5560-5565.
159. Wendling, U., Paul, L., van der Zee, R., Prakken, B. et al., A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J. Immunol. 2000, 164, 2711-2717.
160. Quintana, F. J., Carmi, P., Mor, F., Cohen, I. R., Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum. 2004, 50, 3712-3720.
161. van Eden, W., van der Zee, R., Prakken, B., Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. 2005, 5, 318-330.
162. Yeo, M., Park, H. K., Kim, D. K., Cho, S. W. et al., Restoration of heat shock protein70 suppresses gastric mucosal inducible nitric oxide synthase expression induced by Helicobacter pylori. Proteomics 2004, 4, 3335-3342.
163. Pockley, A. G., Muthana, M., Calderwood, S. K., The dual immunoregulatory roles of str proteins. Trends Biochem. Sci. 2008, 33, 71-79.
164. Fountoulakis, M., Kossida, S., Proteomics-driven progress in neurodegeneration research. Electrophoresis 2006, 27, 1556-1573.
165. Richter-Landsberg, C., Goldbaum, O., Stress proteins in neural cells: functional roles in health and disease. Cell. Mol. Life Sci. 2003, 60, 337-349.
166. Hamacher, M., Meyer, H. E., Great mood in proteomics: Beijing and the HUPO Human Brain Proteome Project. Proteomics 2005, 5, 334-336.
167. Kim, H. J., Hwang, N. R., Lee, K. J., Heat shock responses for understanding diseases of protein denaturation. Mol. Cells 2007, 23, 123-131.
168. Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., Link, C. D., Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. USA 2002, 99, 9439-9444.
169. Fonte, V., Kipp, D. R., Yerg III. J., Merin, D. et al., Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J. Biol. Chem. 2008, 283, 784-791.
170. Kakimura, J., Kitamura, Y., Takata, K., Umeki, M. et al., Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 2002, 16, 601-603.
171. Pridgeon, J. W., Olzmann, J. A., Chin, L. S., Li, L., PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5, e172.
172. Xun, Z., Kaufman, T. C., Clemmer, D. E., Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease. J. Proteome Res. 2008, 7, 3911-3921.
173. Ahn, T. B., Jeon, B. S., Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells. Brain Res. 2006, 1087, 159-167.
174. Shen, H. Y., He, J. C., Wang, Y., Huang, Q. Y., Chen, J. F., Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice. J. Biol. Chem. 2005, 280, 39962-39969.
175. Ganadu, M. L., Aru, M., Mura, G. M., Coi, A. et al., Effects of divalent metal ions on the alphaB-crystallin chaperone-like activity: spectroscopic evidence for a complex between copper(II) and protein. J. Inorg. Biochem. 2004, 98, 1103-1109.
176. Douglas, P. M., Treusch, S., Ren, H. Y., Halfmann, R. et al., Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc. Natl. Acad. Sci. USA 2008, 105, 7206-7211.
177. Chich, J. F., Schaeffer, B., Bouin, A. P., Mouthon, F. et al., Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug. Biochim. Biophys. Acta 2007, 1774, 154-167.
178. Jain, M. R., Ge, W. W., Elkabes, S., Li, H., Amyotrophic lateral sclerosis: protein chaperone dysfunction revealed by proteomic studies of animal models. Proteomics Clin. Appl. 2008, 2, 670-684.
179. Scatena, R., Martorana, G. E., Bottoni, P., Botta, G. et al., An update on pharmacological approaches to neurodegenerative diseases. Expert Opin. Investig. Drugs 2007, 16, 59-72.
180. Yamashita, H., Kawamata, J., Okawa, K., Kanki, R. et al., Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS. J. Neurochem. 2007, 102, 1497-1505.
181. Gal, J., Strom, A. L., Kilt, R., Zhang, F., Zhu, H., p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282, 11068-11077.
182. Shinder, G. A., Lacourse, M. C., Minotti, S., Durham, H. D., Mutant Cu/ Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 2001, 276, 12791-12796.